5 things to know about AmSurg shares hitting $72.63 average price target

Analysts gave AmSurg shares a "buy" rating, updating the price target to $72.63.

Here are five things to know:

1. Nine ratings firms covering AmSurg stock provided the "buy " rating.

2. Christopher Holden, CEO of AmSurg, sold 3,000 shares of stock on June 3.

3. Shares were sold at an average price of $60.09 for a total transaction worth $207,060.

4. AmSurg shares traded up 0.23 percent last Thursday, reaching $70.36.

5. The stock has a 50-day moving average of $69.27 and a 200-day moving average of $61.66. The market cap is $3.35 billion.



For more ASC news:
38 spine-driven ASCs to know | 2015
Go beyond analytics: How business intelligence can make ASCs more money (Part 2)
Opportunities during times of change: Key strategies for orthopedic centers

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Articles We Think You'll Like

 

Featured Whitepapers

Featured Webinars